2025-02-25 Senate Journal

hist199597 Referred to the joint committee for review of Administrative Rules, February 25, 2025.

Senate Clearinghouse Rule 24-024

Relating to excluding Fenfluramine.

hist199598 No action taken on February 25, 2025.

hist199599 Referred to the joint committee for review of Administrative Rules, February 25, 2025.

Senate Clearinghouse Rule 24-033

Relating to monitored prescription drug history reports.

hist199600 No action taken on February 25, 2025.

hist199601 Referred to the joint committee for review of Administrative Rules, February 25, 2025.

Senate Clearinghouse Rule 24-048

Relating to transferring Flualprazolam and scheduling four (4) synthetic benzodiazepine substances.

hist199602 No action taken on February 25, 2025.

hist199603 Referred to the joint committee for review of Administrative Rules, February 25, 2025.

Senate Clearinghouse Rule 24-058

Relating to scheduling Zuranolone.

hist199604 No action taken on February 25, 2025.

hist199605 Referred to the joint committee for review of Administrative Rules, February 25, 2025.

Senate Clearinghouse Rule 24-059

Relating to scheduling nine fentanyl-related substances.

hist199606 No action taken on February 25, 2025.

hist199607 Referred to the joint committee for review of Administrative Rules, February 25, 2025.

Senate Clearinghouse Rule 24-060

Relating to mail delivered prescriptions.

hist199609 No action taken on February 25, 2025.

hist199610 Referred to the joint committee for review of Administrative Rules, February 25, 2025.

JESSE JAMES

Chairperson

63